Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-009134
Filing Date
2024-01-17
Accepted
2024-01-17 13:49:56
Documents
4
Period of Report
2024-01-17

Document Format Files

Seq Description Document Type Size
1 6-K d176707d6k.htm 6-K 9293
2 EX-99.1 d176707dex991.htm EX-99.1 10841
3 GRAPHIC g176707dsp_4.jpg GRAPHIC 2220
4 GRAPHIC g176707g0117174320609.jpg GRAPHIC 2601
  Complete submission text file 0001193125-24-009134.txt   28281
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 24537757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)